Lafeuille, M., Tandon, N., Tiggelaar, S., Kamstra, R., Lefebvre, P., Kim, E., . . . Joshi, K. (2018). Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics. Drugs Real World Outcomes.
Citação norma ChicagoLafeuille, Marie-Hélène, Neeta Tandon, Sean Tiggelaar, Rhiannon Kamstra, Patrick Lefebvre, Edward Kim, Yong Yue, and Kruti Joshi. "Economic Impact in Medicaid Beneficiaries With Schizophrenia and Cardiometabolic Comorbidities Treated With Once-Monthly Paliperidone Palmitate Vs. Oral Atypical Antipsychotics." Drugs Real World Outcomes 2018.
Citação norma MLALafeuille, Marie-Hélène, et al. "Economic Impact in Medicaid Beneficiaries With Schizophrenia and Cardiometabolic Comorbidities Treated With Once-Monthly Paliperidone Palmitate Vs. Oral Atypical Antipsychotics." Drugs Real World Outcomes 2018.